Abstract |
Phosphoglucomutase 3 (PGM3) is an enzyme converting N-acetyl-glucosamine-6-phosphate to N-acetyl-glucosamine-1-phosphate, a precursor important for glycosylation. Mutations in the PGM3 gene have recently been identified as the cause of novel primary immunodeficiency with a hyper- IgE like syndrome. Here we report the occurrence of a homozygous mutation in the PGM3 gene in a family with immunodeficient children, described already in 1976. DNA from two of the immunodeficient siblings was sequenced and shown to encode the same homozygous missense mutation, causing a destabilized protein with reduced enzymatic capacity. Affected individuals were highly prone to infections, but lack the developmental defects in the nervous and skeletal systems, reported in other families. Moreover, normal IgE levels were found. Thus, belonging to the expanding group of congenital glycosylation defects, PGM3 deficiency is characterized by immunodeficiency, with or without increased IgE levels, and with variable forms of developmental defects affecting other organ systems.
|
Authors | Karin E Lundin, Abdulrahman Hamasy, Paul Hoff Backe, Lotte N Moens, Elin Falk-Sörqvist, Katja B Elgstøen, Lars Mørkrid, Magnar Bjørås, Carl Granert, Anna-Carin Norlin, Mats Nilsson, Birger Christensson, Stephan Stenmark, C I Edvard Smith |
Journal | Clinical immunology (Orlando, Fla.)
(Clin Immunol)
Vol. 161
Issue 2
Pg. 366-72
(Dec 2015)
ISSN: 1521-7035 [Electronic] United States |
PMID | 26482871
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- PGM3 protein, human
- Phosphoglucomutase
|
Topics |
- Adult
- Base Sequence
- Blotting, Western
- Cells, Cultured
- DNA Mutational Analysis
- Family Health
- Fatal Outcome
- Female
- Genetic Predisposition to Disease
(genetics)
- Humans
- Immunologic Deficiency Syndromes
(genetics, metabolism)
- Infections
(genetics)
- Male
- Middle Aged
- Mutation
- Pedigree
- Phosphoglucomutase
(genetics, metabolism)
- Siblings
|